Non-Surgical Rhinoplasty Expert, Dr. Alexander Rivkin, Contributes to Landmark Study on Hyaluronidase Use in Aesthetic Medicine

Dr. Alexander Rivkin, a global pioneer in Non-Surgical Rhinoplasty, contributes to an award winning international study on hyaluronidase use, highlighting the enzyme's critical role in aesthetic safety and filler complication management.

LOS ANGELES, March 25, 2025 /PRNewswire/ -- Internationally renowned aesthetic expert Dr. Alexander Rivkin, best known for pioneering the Non-Surgical Rhinoplasty procedure, helped author a newly published study that addresses the vital role of hyaluronidase in aesthetic medicine. The paper, titled "The Use of Hyaluronidase in Aesthetic Practice: A Comparative Study of Practitioner Usage in Elective and Emergency Situations," appears in the Aesthetic Surgery Journal and won a best paper of the year award for 2024. It provides a comprehensive analysis of how this critical enzyme is used to manage complications and improve outcomes in patients treated with dermal fillers.

Hyaluronic acid (HA) fillers remain the most popular injectable treatments worldwide, but complications such as ischemia, blindness, necrosis, and filler migration require immediate intervention. Hyaluronidase is the only agent capable of safely dissolving HA fillers, making it an indispensable tool in both routine corrections and urgent aesthetic emergencies.

"Knowing how to use hyaluronidase correctly is absolutely essential to patient safety in this field," said Dr. Rivkin. "This study sheds light on the variability in how it's used across the world and the urgent need for standardized guidelines to help practitioners respond quickly and effectively to complications."

The study surveyed 264 healthcare professionals worldwide and revealed a lack of uniform protocols for hyaluronidase preparation, dosing, and emergency use. Encouragingly, the data showed that serious adverse reactions to HYAL are rare—92% of respondents had never witnessed an acute reaction, and only 1% had seen a case of anaphylaxis.

Dr. Rivkin's contribution to the study underscores his commitment to advancing non-surgical aesthetic medicine and enhancing patient safety through clinical research and education. As a pioneer of the Non-Surgical Rhinoplasty technique—widely recognized and performed by aesthetic professionals around the globe—Dr. Rivkin continues to shape the field through innovation, teaching, and research.

The full study is available online at: https://pubmed.ncbi.nlm.nih.gov/38262634/

More about Dr. Alexander Rivkin and RIVKIN Aesthetics:

Dr. Alexander Rivkin received his undergraduate degree from Columbia University and his medical degree from Yale University School of Medicine. Dr. Rivkin completed his residency in Otolaryngology/Head and Neck Surgery at the University of California, San Diego School of Medicine. He divides his time between patient care, clinical research, physician education, media appearances, and lecturing throughout the world. RIVKIN Westside Aesthetics, located at 11645 Wilshire Blvd., Suite 800 in Los Angeles, CA, excels at providing state-of-the-art non-surgical aesthetic procedures that compete with the outcomes of plastic surgery. The practice specializes in delivering non-invasive treatments in an intimate and luxurious setting, ensuring optimal cosmetic outcomes while prioritizing patient safety. Dr. Rivkin and his team offer a wide range of services, including non-surgical rhinoplasty, facial rejuvenation, and skin tightening procedures. For more information on the services Dr. Alexander Rivkin offers, please visit http://www.westsideaesthetics.com or call (310) 443-5273.

Media Contact:
Jonas
RIVKIN Aesthetics
Phone: 310-443-5273
Email: [email protected]
Website: https://westsideaesthetics.com

SOURCE RIVKIN Aesthetics